◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

HEALTHTECH SOLUTIONS, INC./UT

CIK: 1307624 SIC: 3841
-
Revenue
$-3.17M
Net Income
-
Gross Margin
-
Op. Margin
$-4.63M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 7 quarterly reports available
Breakdown Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Q1 2021
(Mar 31, 2021)
+ Total Revenue $911.47K $776.22K - - - - -
Revenue Growth % (YoY) nan% nan% nan% nan% nan% nan% nan%
Cost of Revenue $72.02K $51.83K - - - - -
+ Gross Profit $839.45K $724.39K - - - - -
Gross Margin % 92.1% 93.3% nan% nan% nan% nan% nan%
Operating Expenses $1.67M $1.57M $979.80K $801.35K $2.03M $1.21M $262.49K
Research & Development $376.61K $415.95K $593.23K $385.42K $-187.09K $150.13K $84.95K
+ Operating Income $-831.24K $-844.92K $-979.80K $-801.35K $-2.03M $-1.21M $-262.49K
Operating Margin % -91.2% -108.9% nan% nan% nan% nan% nan%
Interest Expense - - - - - $61.00 -
Other Income/Expense - - - - $6.60M - $-31.39K
Income Before Tax $-831.24K $-844.92K $-979.80K - $-2.03M - -
Income Tax Expense - - - - - - -
+ Net Income $-865.99K $-736.08K $-764.88K $-801.35K $-2.84M $-1.21M $-293.88K
Net Margin % -95.0% -94.8% nan% nan% nan% nan% nan%
Basic EPS 0.00 -0.01 nan nan 0.00 nan nan
Basic Shares Outstanding 980K 67.3M - - 9.5M - -
Breakdown Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Q1 2021
(Mar 31, 2021)
Cash & Cash Equivalents $97.59K $192.01K $69.19K $99.69K $7.11K $38.96K $6.29K
Accounts Receivable $1.24M $720.78K - - - - -
Inventory $403.60K $198.53K - - - - -
Total Current Assets $2.46M $1.33M $462.85K $531.01K $313.10K $120.42K $6.29K
Property Plant & Equipment $83.33K $93.33K $103.33K - - - -
Goodwill - - - - - $1.10M -
Intangible Assets $95.44K $106.89K $118.34K $129.80K - - $16.20K
Total Assets $2.75M $1.64M $794.52K $884.14K $423.10K $1.22M $22.50K
Accounts Payable - - - - - $174.21K $96.56K
Total Current Liabilities $5.83M $4.49M $3.22M $2.33M $1.07M $1.24M $160.77K
Total Liabilities $5.83M $4.49M $3.22M $2.33M $1.07M $1.24M $874.41K
Common Stock $72.22K $69.97K $66.97K $66.97K $66.97K $29.15K $9.70K
Retained Earnings $-13.68M $-12.66M $-11.83M $-11.22M $-10.55M $-7.71M $-1.73M
Total Stockholders Equity $-2.75M $-2.34M $-1.93M $-1.32M $-647.56K $-12.46K $-851.91K
Total Liabilities & Equity $2.75M $1.64M $794.52K $884.14K $423.10K $1.22M $22.50K
Breakdown Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Q2 2022
(Jun 30, 2022)
Q1 2022
(Mar 31, 2022)
Q4 2021
(Dec 31, 2021)
Q3 2021
(Sep 30, 2021)
Q1 2021
(Mar 31, 2021)
Net Income $-865.99K $-2.18M $-764.88K $-801.35K $-2.84M $-6.27M $-293.88K
Depreciation & Amortization $10.00K $26.67K $16.67K $6.67K - - -
Stock-based Compensation - - - - - $1.03M -
Change in Receivables $637.67K $776.22K - - - - -
Change in Inventory $253.04K $220.71K - - - - -
Change in Payables - - - $150.35K $569.91K $83.66K $96.56K
Operating Cash Flow $-578.46K $-1.99M $-1.50M $-565.65K $345.78K $-1.57M $-226.38K
Investing Cash Flow - - - - $-644.02K $-437.06K -
Stock Issued - - - - - $1.79M -
Financing Cash Flow $484.04K $2.17M $1.57M $658.25K $266.38K $1.92M $103.68K
Net Change in Cash - - - - - $-90.04K -
SEC Filing Format - Data shown as it appears in the Q3 2022 (10-Q) filing Period ended: Sep 30, 2022
Condensed Consolidated Statements of Operations
Description Sep 30, 2022 Sep 30, 2022
Current Prior Year Current YTD Prior Year YTD
Total Revenue $776.22K - $776.22K -
Cost of Revenue $51.83K - $51.83K -
Gross Profit $724.39K - $724.39K -
Operating Expenses $1.57M - $3.35M -
Research & Development $415.95K - $1.39M -
Operating Income $-844.92K - $-2.63M -
Interest Expense - - - -
Other Income/Expense - - - -
Income Before Tax $-844.92K - $-2.63M -
Income Tax Expense - - - -
Net Income $-736.08K $-4.78M $-2.18M -
Basic EPS -0.01 - -0.04 -
Basic Shares Outstanding $67.33M - $67.09M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2022 Dec 31, 2021
Cash & Cash Equivalents $192.01K $7.11K
Accounts Receivable $720.78K -
Inventory $198.53K -
Total Current Assets $1.33M $313.10K
Property Plant & Equipment $93.33K -
Intangible Assets $106.89K -
Total Assets $1.64M $423.10K
Total Current Liabilities $4.49M $1.07M
Total Liabilities $4.49M $1.07M
Common Stock $69.97K $66.97K
Retained Earnings $-12.66M $-10.55M
Total Stockholders Equity $-2.34M $-647.56K
Total Liabilities & Equity $1.64M $423.10K
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2022 Sep 30, 2022
Current Prior Year Current YTD Prior Year YTD
Net Income $-736.08K - $-2.18M -
Depreciation & Amortization $21.45K - $26.67K -
Stock-based Compensation - - - -
Change in Receivables - - $776.22K -
Change in Inventory - - $220.71K -
Operating Cash Flow - - $-1.99M -
Acquisitions - - - -
Investing Cash Flow - - - -
Financing Cash Flow - - $2.17M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...